For example, in a rat model of non-alcoholic fatty liver disease (NAFLD) induced by a high-fat diet (HFD), treatment with a JNK inhibitor attenuated insulin resistance [53]. This evidence concerns the gene MAPK8 and metabolic dysfunction-associated steatotic liver disease.